(PhysOrg.com) -- UConn researchers are developing techniques to detect biomarker proteins that can indicate the presence of cancer before symptoms are apparent.
Modern genetic testing can predict your risk of contracting particular diseases based on predispositions discovered in your DNA. But what if similar biotechnology could tell you that you’ve got a disease before you notice any symptoms? What if it could even tell you, before any signs of a tumor, that...
Maggie Fox, Health and Science Editor
WASHINGTON
Mon Apr 19, 2010 12:42pm EDT
(Reuters) - Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co's Evista, but with a greater risk of some other cancers and blood clots.
After nearly seven years of follow-up, researchers found that women who took tamoxifen for five years were less likely to develop breast cancer than those...
Maggie Fox, Health and Science Editor - Analysis
WASHINGTON
Tue Apr 20, 2010 10:00am EDT
(Reuters) - The results are in and clear -- taking a pill a day for five years can slash the risk of breast cancer. But high-risk women are still reluctant to do it.
The cancer specialists who have been comparing the drugs raloxifene and tamoxifen rushed out updated findings to a meeting on Monday, showing that tamoxifen lowers the risk of breast cancer in high-risk women...
By Nancy Walsh, Contributing Writer, MedPage Today
Published: May 26, 2009
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner
RIDGEWOOD, N.J., May 26 -- Postmenopausal women at increased risk for breast cancer may benefit from taking either tamoxifen or raloxifene, according to an updated guideline from the American Society of Clinical Oncology. ...
Last Updated: 2009-03-10 16:00:32 -0400 (Reuters Health)
NEW YORK (Reuters Health) - Screening for breast cancer risk in postmenopausal women, based on breast density and other factors, identifies patients at high risk who would benefit from chemoprophylaxis and lifestyle changes, according to a report in the Journal of the National Cancer Institute for March 18.
"Although mammographic screening results in decreased mortality from breast cancer, it does not reduce...
